Japanese Auto Stocks Gain on a Weaker Yen
By Megumi Fujikawa
TOKYO--Japanese auto stocks gained early Thursday as the yen weakened versus the dollar on market views that the Federal Reserve may opt for smaller rate cuts ahead.
The index for the Japanese auto shares was up 4.1% in morning trade with the yen trading around 143.60 to the dollar.
Toyota Motor shares rose 5.1% and Honda Motor was up 4.2%.
The Federal Reserve cut interest rates by a half-percentage but the dollar rose against the yen as Fed Chair Jerome Powell suggested that the central bank wouldn't keep cutting rates at the same pace.
"I do not think that anyone should look at this and say, oh, this is the new pace," Powell said at a news conference Wednesday.
A weaker yen is positive for Japanese exporters because it makes their products more price-competitive in the global markets and boosts their overseas earnings when repatriated to Japan.
"Japanese stocks are undervalued and will likely rise significantly in the long term," Rakuten Securities strategist Masayuki Kubota said and recommended investors to keep buying Japanese shares.
The Nikkei Stock Average was recently up 1.9% at 37084.48.
Write to Megumi Fujikawa at megumi.fujikawa@wsj.com
(END) Dow Jones Newswires
September 18, 2024 21:51 ET (01:51 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks